APA (7th ed.) Citation

M, F., R, B., M, S., MA, M., T, K., W, W., . . . P, V. (2025). Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes. Neuro-oncology, 27(7), 1878. https://doi.org/10.1093/neuonc/noaf070

Chicago Style (17th ed.) Citation

M, Foltyn-Dumitru, et al. "Histopathological and Molecular Characteristics of IDH-wildtype Glioblastoma Without Contrast Enhancement: Implications for Clinical Outcomes." Neuro-oncology 27, no. 7 (2025): 1878. https://doi.org/10.1093/neuonc/noaf070.

MLA (9th ed.) Citation

M, Foltyn-Dumitru, et al. "Histopathological and Molecular Characteristics of IDH-wildtype Glioblastoma Without Contrast Enhancement: Implications for Clinical Outcomes." Neuro-oncology, vol. 27, no. 7, 2025, p. 1878, https://doi.org/10.1093/neuonc/noaf070.